Global Recombinant Human Endostatin Market Growth 2025-2031

January 2025 | 80 pages | ID: G04F763C666CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Recombinant Human Endostatin market size is predicted to grow from US$ 157 million in 2025 to US$ 254 million in 2031; it is expected to grow at a CAGR of 8.3% from 2025 to 2031.

Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162?302 and Cys264?294.

The market for recombinant human endostatin is important in cancer treatment. Trends include research into combination therapies and targeted cancer treatments.

LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Endostatin Industry Forecast” looks at past sales and reviews total world Recombinant Human Endostatin sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Human Endostatin sales for 2025 through 2031. With Recombinant Human Endostatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Endostatin industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Human Endostatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Endostatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Endostatin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Endostatin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Endostatin.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Endostatin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Purity:95%
• Others

Segmentation by Application:

• Medical Care
• Scientific Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• PeproTech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Recombinant Human Endostatin market?

What factors are driving Recombinant Human Endostatin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Recombinant Human Endostatin market opportunities vary by end market size?

How does Recombinant Human Endostatin break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Human Endostatin Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Recombinant Human Endostatin by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Recombinant Human Endostatin by Country/Region, 2020, 2024 & 2031
2.2 Recombinant Human Endostatin Segment by Type
  2.2.1 Purity:95%
  2.2.2 Others
2.3 Recombinant Human Endostatin Sales by Type
  2.3.1 Global Recombinant Human Endostatin Sales Market Share by Type (2020-2025)
  2.3.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Recombinant Human Endostatin Sale Price by Type (2020-2025)
2.4 Recombinant Human Endostatin Segment by Application
  2.4.1 Medical Care
  2.4.2 Scientific Research
  2.4.3 Others
2.5 Recombinant Human Endostatin Sales by Application
  2.5.1 Global Recombinant Human Endostatin Sale Market Share by Application (2020-2025)
  2.5.2 Global Recombinant Human Endostatin Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Recombinant Human Endostatin Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Recombinant Human Endostatin Breakdown Data by Company
  3.1.1 Global Recombinant Human Endostatin Annual Sales by Company (2020-2025)
  3.1.2 Global Recombinant Human Endostatin Sales Market Share by Company (2020-2025)
3.2 Global Recombinant Human Endostatin Annual Revenue by Company (2020-2025)
  3.2.1 Global Recombinant Human Endostatin Revenue by Company (2020-2025)
  3.2.2 Global Recombinant Human Endostatin Revenue Market Share by Company (2020-2025)
3.3 Global Recombinant Human Endostatin Sale Price by Company
3.4 Key Manufacturers Recombinant Human Endostatin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Recombinant Human Endostatin Product Location Distribution
  3.4.2 Players Recombinant Human Endostatin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN ENDOSTATIN BY GEOGRAPHIC REGION

4.1 World Historic Recombinant Human Endostatin Market Size by Geographic Region (2020-2025)
  4.1.1 Global Recombinant Human Endostatin Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Recombinant Human Endostatin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Recombinant Human Endostatin Market Size by Country/Region (2020-2025)
  4.2.1 Global Recombinant Human Endostatin Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Recombinant Human Endostatin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Human Endostatin Sales Growth
4.4 APAC Recombinant Human Endostatin Sales Growth
4.5 Europe Recombinant Human Endostatin Sales Growth
4.6 Middle East & Africa Recombinant Human Endostatin Sales Growth

5 AMERICAS

5.1 Americas Recombinant Human Endostatin Sales by Country
  5.1.1 Americas Recombinant Human Endostatin Sales by Country (2020-2025)
  5.1.2 Americas Recombinant Human Endostatin Revenue by Country (2020-2025)
5.2 Americas Recombinant Human Endostatin Sales by Type (2020-2025)
5.3 Americas Recombinant Human Endostatin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Endostatin Sales by Region
  6.1.1 APAC Recombinant Human Endostatin Sales by Region (2020-2025)
  6.1.2 APAC Recombinant Human Endostatin Revenue by Region (2020-2025)
6.2 APAC Recombinant Human Endostatin Sales by Type (2020-2025)
6.3 APAC Recombinant Human Endostatin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Recombinant Human Endostatin by Country
  7.1.1 Europe Recombinant Human Endostatin Sales by Country (2020-2025)
  7.1.2 Europe Recombinant Human Endostatin Revenue by Country (2020-2025)
7.2 Europe Recombinant Human Endostatin Sales by Type (2020-2025)
7.3 Europe Recombinant Human Endostatin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Human Endostatin by Country
  8.1.1 Middle East & Africa Recombinant Human Endostatin Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Recombinant Human Endostatin Revenue by Country (2020-2025)
8.2 Middle East & Africa Recombinant Human Endostatin Sales by Type (2020-2025)
8.3 Middle East & Africa Recombinant Human Endostatin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Endostatin
10.3 Manufacturing Process Analysis of Recombinant Human Endostatin
10.4 Industry Chain Structure of Recombinant Human Endostatin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Recombinant Human Endostatin Distributors
11.3 Recombinant Human Endostatin Customer

12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN ENDOSTATIN BY GEOGRAPHIC REGION

12.1 Global Recombinant Human Endostatin Market Size Forecast by Region
  12.1.1 Global Recombinant Human Endostatin Forecast by Region (2026-2031)
  12.1.2 Global Recombinant Human Endostatin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Recombinant Human Endostatin Forecast by Type (2026-2031)
12.7 Global Recombinant Human Endostatin Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Thermo Fisher Scientific
  13.1.1 Thermo Fisher Scientific Company Information
  13.1.2 Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolios and Specifications
  13.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Thermo Fisher Scientific Main Business Overview
  13.1.5 Thermo Fisher Scientific Latest Developments
13.2 PeproTech
  13.2.1 PeproTech Company Information
  13.2.2 PeproTech Recombinant Human Endostatin Product Portfolios and Specifications
  13.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 PeproTech Main Business Overview
  13.2.5 PeproTech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Recombinant Human Endostatin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Recombinant Human Endostatin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity:95%
Table 4. Major Players of Others
Table 5. Global Recombinant Human Endostatin Sales byType (2020-2025) & (K Pcs)
Table 6. Global Recombinant Human Endostatin Sales Market Share byType (2020-2025)
Table 7. Global Recombinant Human Endostatin Revenue byType (2020-2025) & ($ million)
Table 8. Global Recombinant Human Endostatin Revenue Market Share byType (2020-2025)
Table 9. Global Recombinant Human Endostatin Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Recombinant Human Endostatin Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Recombinant Human Endostatin Sale Market Share by Application (2020-2025)
Table 12. Global Recombinant Human Endostatin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Recombinant Human Endostatin Revenue Market Share by Application (2020-2025)
Table 14. Global Recombinant Human Endostatin Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Recombinant Human Endostatin Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Recombinant Human Endostatin Sales Market Share by Company (2020-2025)
Table 17. Global Recombinant Human Endostatin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Recombinant Human Endostatin Revenue Market Share by Company (2020-2025)
Table 19. Global Recombinant Human Endostatin Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Recombinant Human Endostatin Producing Area Distribution and Sales Area
Table 21. Players Recombinant Human Endostatin Products Offered
Table 22. Recombinant Human Endostatin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Recombinant Human Endostatin Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Recombinant Human Endostatin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Recombinant Human Endostatin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Recombinant Human Endostatin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Recombinant Human Endostatin Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Recombinant Human Endostatin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Recombinant Human Endostatin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Recombinant Human Endostatin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Recombinant Human Endostatin Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Recombinant Human Endostatin Sales Market Share by Country (2020-2025)
Table 35. Americas Recombinant Human Endostatin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Recombinant Human Endostatin Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Recombinant Human Endostatin Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Recombinant Human Endostatin Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Recombinant Human Endostatin Sales Market Share by Region (2020-2025)
Table 40. APAC Recombinant Human Endostatin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Recombinant Human Endostatin Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Recombinant Human Endostatin Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Recombinant Human Endostatin Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Recombinant Human Endostatin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Recombinant Human Endostatin Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Recombinant Human Endostatin Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Recombinant Human Endostatin Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Recombinant Human Endostatin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Recombinant Human Endostatin Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Recombinant Human Endostatin Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Recombinant Human Endostatin
Table 52. Key Market Challenges & Risks of Recombinant Human Endostatin
Table 53. Key IndustryTrends of Recombinant Human Endostatin
Table 54. Recombinant Human Endostatin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Recombinant Human Endostatin Distributors List
Table 57. Recombinant Human Endostatin Customer List
Table 58. Global Recombinant Human Endostatin SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Recombinant Human Endostatin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Recombinant Human Endostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Recombinant Human Endostatin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Recombinant Human Endostatin SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Recombinant Human Endostatin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Recombinant Human Endostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Recombinant Human Endostatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Recombinant Human Endostatin SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Recombinant Human Endostatin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Recombinant Human Endostatin SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Recombinant Human Endostatin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Recombinant Human Endostatin SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Recombinant Human Endostatin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72.ThermoFisher Scientific Basic Information, Recombinant Human Endostatin Manufacturing Base, Sales Area and Its Competitors
Table 73.ThermoFisher Scientific Recombinant Human Endostatin Product Portfolios and Specifications
Table 74.ThermoFisher Scientific Recombinant Human Endostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75.ThermoFisher Scientific Main Business
Table 76.ThermoFisher Scientific Latest Developments
Table 77. PeproTech Basic Information, Recombinant Human Endostatin Manufacturing Base, Sales Area and Its Competitors
Table 78. PeproTech Recombinant Human Endostatin Product Portfolios and Specifications
Table 79. PeproTech Recombinant Human Endostatin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. PeproTech Main Business
Table 81. PeproTech Latest Developments



LIST OFFIGURES

Figure 1. Picture of Recombinant Human Endostatin
Figure 2. Recombinant Human Endostatin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Endostatin Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Recombinant Human Endostatin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Recombinant Human Endostatin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Recombinant Human Endostatin Sales Market Share by Country/Region (2024)
Figure 10. Recombinant Human Endostatin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity:95%
Figure 12. Product Picture of Others
Figure 13. Global Recombinant Human Endostatin Sales Market Share byType in 2025
Figure 14. Global Recombinant Human Endostatin Revenue Market Share byType (2020-2025)
Figure 15. Recombinant Human Endostatin Consumed in Medical Care
Figure 16. Global Recombinant Human Endostatin Market: Medical Care (2020-2025) & (K Pcs)
Figure 17. Recombinant Human Endostatin Consumed in Scientific Research
Figure 18. Global Recombinant Human Endostatin Market: Scientific Research (2020-2025) & (K Pcs)
Figure 19. Recombinant Human Endostatin Consumed in Others
Figure 20. Global Recombinant Human Endostatin Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Recombinant Human Endostatin Sale Market Share by Application (2024)
Figure 22. Global Recombinant Human Endostatin Revenue Market Share by Application in 2025
Figure 23. Recombinant Human Endostatin Sales by Company in 2025 (K Pcs)
Figure 24. Global Recombinant Human Endostatin Sales Market Share by Company in 2025
Figure 25. Recombinant Human Endostatin Revenue by Company in 2025 ($ millions)
Figure 26. Global Recombinant Human Endostatin Revenue Market Share by Company in 2025
Figure 27. Global Recombinant Human Endostatin Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Recombinant Human Endostatin Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Recombinant Human Endostatin Sales 2020-2025 (K Pcs)
Figure 30. Americas Recombinant Human Endostatin Revenue 2020-2025 ($ millions)
Figure 31. APAC Recombinant Human Endostatin Sales 2020-2025 (K Pcs)
Figure 32. APAC Recombinant Human Endostatin Revenue 2020-2025 ($ millions)
Figure 33. Europe Recombinant Human Endostatin Sales 2020-2025 (K Pcs)
Figure 34. Europe Recombinant Human Endostatin Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Recombinant Human Endostatin Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Recombinant Human Endostatin Revenue 2020-2025 ($ millions)
Figure 37. Americas Recombinant Human Endostatin Sales Market Share by Country in 2025
Figure 38. Americas Recombinant Human Endostatin Revenue Market Share by Country (2020-2025)
Figure 39. Americas Recombinant Human Endostatin Sales Market Share byType (2020-2025)
Figure 40. Americas Recombinant Human Endostatin Sales Market Share by Application (2020-2025)
Figure 41. United States Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Recombinant Human Endostatin Sales Market Share by Region in 2025
Figure 46. APAC Recombinant Human Endostatin Revenue Market Share by Region (2020-2025)
Figure 47. APAC Recombinant Human Endostatin Sales Market Share byType (2020-2025)
Figure 48. APAC Recombinant Human Endostatin Sales Market Share by Application (2020-2025)
Figure 49. China Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 53. India Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Recombinant Human Endostatin Sales Market Share by Country in 2025
Figure 57. Europe Recombinant Human Endostatin Revenue Market Share by Country (2020-2025)
Figure 58. Europe Recombinant Human Endostatin Sales Market Share byType (2020-2025)
Figure 59. Europe Recombinant Human Endostatin Sales Market Share by Application (2020-2025)
Figure 60. Germany Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 61.France Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Recombinant Human Endostatin Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Recombinant Human Endostatin Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Recombinant Human Endostatin Sales Market Share by Application (2020-2025)
Figure 68. Egypt Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Recombinant Human Endostatin Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Recombinant Human Endostatin in 2025
Figure 74. Manufacturing Process Analysis of Recombinant Human Endostatin
Figure 75. Industry Chain Structure of Recombinant Human Endostatin
Figure 76. Channels of Distribution
Figure 77. Global Recombinant Human Endostatin Sales MarketForecast by Region (2026-2031)
Figure 78. Global Recombinant Human Endostatin Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Recombinant Human Endostatin Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Recombinant Human Endostatin Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Recombinant Human Endostatin Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Recombinant Human Endostatin Revenue Market ShareForecast by Application (2026-2031)